Cargando…

Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis

BACKGROUND: Drivers of differences in disease presentation and symptom duration in Lyme neuroborreliosis (LNB) are currently unknown. OBJECTIVES: We hypothesized that neurofilament light (NfL) in cerebrospinal fluid (CSF) would predict disease location and sequelae in a historic LNB cohort. DESIGN:...

Descripción completa

Detalles Bibliográficos
Autores principales: Mens, Helene, Fjordside, Lasse, Gynthersen, Rosa M. M., Ørbæk, Mathilde T., Andersen, Åse Bengaard, Andreasson, Ulf, Blennow, Kaj, Sellebjerg, Finn, Zetterberg, Henrik, Lebech, Anne-Mette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272052/
https://www.ncbi.nlm.nih.gov/pubmed/35832609
http://dx.doi.org/10.1177/11795735221098126
_version_ 1784744810488266752
author Mens, Helene
Fjordside, Lasse
Gynthersen, Rosa M. M.
Ørbæk, Mathilde T.
Andersen, Åse Bengaard
Andreasson, Ulf
Blennow, Kaj
Sellebjerg, Finn
Zetterberg, Henrik
Lebech, Anne-Mette
author_facet Mens, Helene
Fjordside, Lasse
Gynthersen, Rosa M. M.
Ørbæk, Mathilde T.
Andersen, Åse Bengaard
Andreasson, Ulf
Blennow, Kaj
Sellebjerg, Finn
Zetterberg, Henrik
Lebech, Anne-Mette
author_sort Mens, Helene
collection PubMed
description BACKGROUND: Drivers of differences in disease presentation and symptom duration in Lyme neuroborreliosis (LNB) are currently unknown. OBJECTIVES: We hypothesized that neurofilament light (NfL) in cerebrospinal fluid (CSF) would predict disease location and sequelae in a historic LNB cohort. DESIGN: Using a cross-sectional design and archived CSF samples from 185 patients diagnosed with LNB, we evaluated the content of NfL in the total cohort and in a subgroup of 84 patients with available clinical and paraclinical information. METHODS: Individuals were categorized according to disease location: a. Central nervous system (CNS) with stroke (N=3), b. CNS without stroke (N=11), c. Peripheral nervous system (PNS) with cranial nerve palsy (CNP) (N=40) d. PNS without CNP (N=30). Patients with hospital follow-up more than 6 months after completed antibiotic therapy were categorized as having LNB associated sequelae (N=15). RESULTS: At diagnosis concentration of NfL exceeded the upper reference level in 60% (105/185), especially among individuals above 30 years. Age-adjusted NfL was not found to be associated with symptom duration. Age-adjusted NfL was significantly higher among individuals with CNS involvement. Category a. (stroke) had significantly higher NfL concentrations in CSF compared to all other categories, category b. (CNS involvement without stroke) had significantly higher values compared to the categories of PNS involvement. We found no significant difference between the categories with PNS involvement (with or without CNP). Significantly higher NfL was found among patients with follow-up in hospital setting. CONCLUSION: Comparison of NfL concentrations between the 4 groups of LNB disease manifestations based on clinical information revealed a hierarchy of neuron damage according to disease location and suggested evolving mechanisms with accelerated injury especially when disease is complicated by stroke. Higher values of NfL among patients with need of follow-up in hospital setting suggest NfL could be useful to identify rehabilitative needs.
format Online
Article
Text
id pubmed-9272052
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-92720522022-07-12 Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis Mens, Helene Fjordside, Lasse Gynthersen, Rosa M. M. Ørbæk, Mathilde T. Andersen, Åse Bengaard Andreasson, Ulf Blennow, Kaj Sellebjerg, Finn Zetterberg, Henrik Lebech, Anne-Mette J Cent Nerv Syst Dis Original Research Article BACKGROUND: Drivers of differences in disease presentation and symptom duration in Lyme neuroborreliosis (LNB) are currently unknown. OBJECTIVES: We hypothesized that neurofilament light (NfL) in cerebrospinal fluid (CSF) would predict disease location and sequelae in a historic LNB cohort. DESIGN: Using a cross-sectional design and archived CSF samples from 185 patients diagnosed with LNB, we evaluated the content of NfL in the total cohort and in a subgroup of 84 patients with available clinical and paraclinical information. METHODS: Individuals were categorized according to disease location: a. Central nervous system (CNS) with stroke (N=3), b. CNS without stroke (N=11), c. Peripheral nervous system (PNS) with cranial nerve palsy (CNP) (N=40) d. PNS without CNP (N=30). Patients with hospital follow-up more than 6 months after completed antibiotic therapy were categorized as having LNB associated sequelae (N=15). RESULTS: At diagnosis concentration of NfL exceeded the upper reference level in 60% (105/185), especially among individuals above 30 years. Age-adjusted NfL was not found to be associated with symptom duration. Age-adjusted NfL was significantly higher among individuals with CNS involvement. Category a. (stroke) had significantly higher NfL concentrations in CSF compared to all other categories, category b. (CNS involvement without stroke) had significantly higher values compared to the categories of PNS involvement. We found no significant difference between the categories with PNS involvement (with or without CNP). Significantly higher NfL was found among patients with follow-up in hospital setting. CONCLUSION: Comparison of NfL concentrations between the 4 groups of LNB disease manifestations based on clinical information revealed a hierarchy of neuron damage according to disease location and suggested evolving mechanisms with accelerated injury especially when disease is complicated by stroke. Higher values of NfL among patients with need of follow-up in hospital setting suggest NfL could be useful to identify rehabilitative needs. SAGE Publications 2022-07-07 /pmc/articles/PMC9272052/ /pubmed/35832609 http://dx.doi.org/10.1177/11795735221098126 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Mens, Helene
Fjordside, Lasse
Gynthersen, Rosa M. M.
Ørbæk, Mathilde T.
Andersen, Åse Bengaard
Andreasson, Ulf
Blennow, Kaj
Sellebjerg, Finn
Zetterberg, Henrik
Lebech, Anne-Mette
Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis
title Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis
title_full Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis
title_fullStr Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis
title_full_unstemmed Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis
title_short Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis
title_sort neurofilament light in cerebrospinal fluid is associated with disease staging in european lyme neuroborreliosis
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272052/
https://www.ncbi.nlm.nih.gov/pubmed/35832609
http://dx.doi.org/10.1177/11795735221098126
work_keys_str_mv AT menshelene neurofilamentlightincerebrospinalfluidisassociatedwithdiseasestagingineuropeanlymeneuroborreliosis
AT fjordsidelasse neurofilamentlightincerebrospinalfluidisassociatedwithdiseasestagingineuropeanlymeneuroborreliosis
AT gynthersenrosamm neurofilamentlightincerebrospinalfluidisassociatedwithdiseasestagingineuropeanlymeneuroborreliosis
AT ørbækmathildet neurofilamentlightincerebrospinalfluidisassociatedwithdiseasestagingineuropeanlymeneuroborreliosis
AT andersenasebengaard neurofilamentlightincerebrospinalfluidisassociatedwithdiseasestagingineuropeanlymeneuroborreliosis
AT andreassonulf neurofilamentlightincerebrospinalfluidisassociatedwithdiseasestagingineuropeanlymeneuroborreliosis
AT blennowkaj neurofilamentlightincerebrospinalfluidisassociatedwithdiseasestagingineuropeanlymeneuroborreliosis
AT sellebjergfinn neurofilamentlightincerebrospinalfluidisassociatedwithdiseasestagingineuropeanlymeneuroborreliosis
AT zetterberghenrik neurofilamentlightincerebrospinalfluidisassociatedwithdiseasestagingineuropeanlymeneuroborreliosis
AT lebechannemette neurofilamentlightincerebrospinalfluidisassociatedwithdiseasestagingineuropeanlymeneuroborreliosis